|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||44.65 - 44.65|
|52-week range||26.37 - 50.20|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||07 Nov 2019|
|1y target est||N/A|
The pharma company which has been looking to bring a new coronavirus vaccine to the market by the end of the year, announced it has initiated a global phase three clinical efficacy study.
With the UK economy opening up, there’s been enthusiasm to buy shares in consumer-driven businesses. But here’s one FTSE 100 stock I would avoid... for now. The post One FTSE 100 reopening stock I’m avoiding appeared first on The Motley Fool UK.
From 17 May, Britons traveling to green list nations don’t need to quarantine when they return to the UK unless the COVID-19 test they take on or before day two after their return is positive.